When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EW - Edwards Lifesciences: High Revenue Growth Already Priced In
Edwards Lifesciences Corporation
TAVR revenue is forecasted to grow at an average growth rate of 14.70% until 2026 supported by the aging population.
We believe Edwards is benefitting heavily from economies of scale as the average SG&A as a percentage of revenue growth rate in the past decade is -3.01%.
Despite its double-digit revenue growth, we find the company fairly valued given its EV/EBITDA multiple of 40.21x is almost double the industry average multiple of 23.29x.